注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
LENSAR Inc是一家商业级医疗器械公司。该公司专注于设计、开发和销售飞秒激光系统,用于治疗白内障和管理预先存在或手术引起的角膜散光。它开发了LENSAR激光系统,以提供一种替代性激光白内障治疗工具,使外科医生能够更好地解决散光问题并改善视觉效果。该公司的产品组合包括带有Streamline IV和IntelliAxis的LENSAR激光系统及其相关耗材组件。该公司还正在开发一种综合性白内障治疗系统,即ALLY Adaptive Cataract Treatment System(ALLY)。ALLY系统旨在将其现有的飞秒激光技术和超声乳化系统结合到一个单元中,使外科医生可以使用该设备在单个手术室中执行白内障手术中的每个关键步骤。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Richard L. Lindstrom | 73 | 2018 | Independent Director |
William J. Link | 75 | 2017 | Independent Chairman |
Gary M. Winer | 61 | 2018 | Independent Director |
Nicholas T. Curtis | 67 | 2012 | President, CEO & Director |
Elizabeth G. O'Farrell | 58 | 2021 | Independent Director |
Mark Packer | - | - | Member of Medical Advisory Board |
William B. Trattler | - | - | Member of Medical Advisory Board |
Denise Visco | - | - | Member of Medical Advisory Board |
Carlos Buznego | - | - | Member of Medical Advisory Board |
Mitchell A. Jackson | - | - | Member of Medical Advisory Board |
Robert J. Weinstock | - | - | Member of Medical Advisory Board |
Gregory D. Parkhurst | - | - | Member of Medical Advisory Board |
Alan Faulkner | - | 2023 | Medical Advisory Board Member |
Aimee S. Weisner | 54 | 2021 | Independent Director |
Todd B. Hammer | - | 2023 | Director |
Thomas B. Ellis | - | 2023 | Director |
Neda Nikpoor | - | 2023 | Medical Advisory Board Member |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核